# 바이오스페이스 일일 뉴스 리포트 - 2025년 08월 20일


## 주요 헤드라인

1. **Viking Crashes as Obesity Pill Delivers Over 12% Weight Loss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/viking-crashes-as-obesity-pill-delivers-over-12-weight-loss>

2. **Viking Crashes as Obesity Pill Delivers Over 12% Weight Loss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/viking-crashes-as-obesity-pill-delivers-over-12-weight-loss>

3. **Conflicts of Interest in Vaccine Committees Have Been Plunging for Decades (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/conflicts-of-interest-in-vaccine-committees-have-been-plunging-for-decades>

4. **Conflicts of Interest in Vaccine Committees Have Been Plunging for Decades (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/conflicts-of-interest-in-vaccine-committees-have-been-plunging-for-decades>

5. **Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/genentech-walks-away-from-2b-partnership-with-adaptive-biotechnologies>

6. **VantAI Links With Halda in Potential $1B+ Proteomics Pact (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vantai-links-with-halda-in-proteomics-pact-worth-up-to-1b>

7. **Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/oral-wegovys-pending-approval-puts-spotlight-on-viability-of-high-dose-peptides>


---
*2025년 08월 20일 바이오스페이스 뉴스 피드에서 생성된 리포트*